Flow Traders U.S. LLC Novo Nordisk A S Transaction History

Flow Traders U.S. LLC

$1.97 Billion
Q3 2024

A detailed history of Flow Traders U.S. LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Flow Traders U.S. LLC holds 24,792 shares of NVO stock, worth $2.12 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

24,792

Previous 2,789 788.92%

Holding current value

$2.12 Million

Previous $398,000 641.71%

% of portfolio

0.15%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $2.62 Million - $3.2 Million	22,003 Added 788.92%	24,792 $2.95 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $2.88 Million - $3.45 Million	-23,502 Reduced 89.39%	2,789 $398,000
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $162,559 - $216,384	1,592 Added 6.45%	26,291 $3.38 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $2.17 Million - $2.6 Million	24,699 New	24,699 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $342,245 - $420,012	3,592 New	3,592 $358,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $188,309 - $222,181	-1,824 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $410,291 - $495,963	-4,407 Reduced 70.73%	1,824 $203,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $281,695 - $343,981	2,938 Added 89.22%	6,231 $698,000
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $1.56 Million - $1.98 Million	-18,525 Reduced 84.91%	3,293 $316,000
Q2 2021 Aug 24, 2021	BUY	$67.66 - $84.76 $1.48 Million - $1.85 Million	21,818 New	21,818 $1.83 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $246,998 - $285,310	-3,866 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $246,225 - $271,470	3,866 New	3,866 $268,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $289,246 - $335,691	-4,941 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $299,381 - $392,113	-6,053 Reduced 55.06%	4,941 $297,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $648,080 - $757,263	-12,998 Reduced 54.18%	10,994 $636,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $1.14 Million - $1.28 Million	23,992 New	23,992 $1.24 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $877,177 - $995,812	-18,921 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$41.54 - $47.25 $98,699 - $112,266	2,376 Added 14.36%	18,921 $872,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $773,644 - $847,765	16,545 New	16,545 $780,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $738,580 - $840,803	-16,676 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $592,547 - $710,470	12,220 Added 274.24%	16,676 $821,000
Q4 2017 Feb 13, 2018	SELL	$47.53 - $53.73 $520,928 - $588,880	-10,960 Reduced 71.09%	4,456 $239,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $410,635 - $491,166	9,979 Added 183.54%	15,416 $742,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,437	5,437 $233,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flow Traders U.S. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flow Traders U.S. LLC with notifications on news.

Account

Flow Traders U.S. LLC Novo Nordisk A S Transaction History